Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Early Short Course Corticosteroids in Hospitalized Patients with COVID-19

Raef Fadel, Austin R. Morrison, Amit Vahia, Zachary R. Smith, Zohra Chaudhry, Pallavi Bhargava, Joseph Miller, Rachel M. Kenney, George Alangaden, View ORCID ProfileMayur S. Ramesh, Henry Ford COVID-19 Management Task Force
doi: https://doi.org/10.1101/2020.05.04.20074609
Raef Fadel
1Internal Medicine, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI, 48202, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Austin R. Morrison
2Pharmacy, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI, 48202, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amit Vahia
3Infectious Diseases, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI, 48202, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zachary R. Smith
2Pharmacy, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI, 48202, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zohra Chaudhry
3Infectious Diseases, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI, 48202, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pallavi Bhargava
3Infectious Diseases, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI, 48202, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Miller
4Emergency Medicine, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI, 48202, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel M. Kenney
2Pharmacy, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI, 48202, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Alangaden
3Infectious Diseases, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI, 48202, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mramesh1@hfhs.org
Mayur S. Ramesh
3Infectious Diseases, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI, 48202, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mayur S. Ramesh
  • For correspondence: galanga1@hfhs.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background There is no proven antiviral or immunomodulatory therapy for COVID-19. The disease progression associated with the pro-inflammatory host response prompted us to examine the role of early corticosteroid therapy in patients with moderate to severe COVID-19.

Methods We conducted a single pre-test, single post-test quasi-experiment in a multi-center health system in Michigan from March 12 to March 27, 2020. Adult patients with confirmed moderate to severe COVID were included. A protocol was implemented on March 20, 2020 using early, short-course, methylprednisolone 0.5 to 1 mg/kg/day divided in 2 intravenous doses for 3 days. Outcomes of pre and post-corticosteroid groups were evaluated. A composite endpoint of escalation of care from ward to ICU, new requirement for mechanical ventilation, and mortality was the primary outcome measure. All patients had at least 14 days of follow-up.

Results We analyzed 213 eligible subjects, 81 (38%) and 132 (62%) in pre-and post-corticosteroid groups, respectively. The composite endpoint occurred at a significantly lower rate in post-corticosteroid group compared to pre-corticosteroid group (34.9% vs. 54.3%, p=0.005). This treatment effect was observed within each individual component of the composite endpoint. Significant reduction in median hospital length of stay was observed in the post-corticosteroid group (8 vs. 5 days, p < 0.001). Multivariate regression analysis demonstrated an independent reduction in the composite endpoint at 14-days controlling for other factors (aOR: 0.45; 95% CI [0.25 – 0.81]).

Conclusion An early short course of methylprednisolone in patients with moderate to severe COVID-19 reduced escalation of care and improved clinical outcomes.

Summary In this multi-center quasi-experimental study of 213 patients, we demonstrate early short course of methylprednisolone in moderate to severe COVID-19 patients reduced the composite endpoint of escalation of care from ward to ICU, new requirement for mechanical ventilation, and mortality.

Competing Interest Statement

SH received speaker’s bureau honoraria from Bayer IB received speaker’s bureau honoraria from Gilead, ViiV and Jansssen All others have no conflicts of interests.

Clinical Trial

Clinicaltrials.gov registration# NCT04374071

Funding Statement

No funding Sources

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will be available after one year from publication.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 05, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
Raef Fadel, Austin R. Morrison, Amit Vahia, Zachary R. Smith, Zohra Chaudhry, Pallavi Bhargava, Joseph Miller, Rachel M. Kenney, George Alangaden, Mayur S. Ramesh, Henry Ford COVID-19 Management Task Force
medRxiv 2020.05.04.20074609; doi: https://doi.org/10.1101/2020.05.04.20074609
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
Raef Fadel, Austin R. Morrison, Amit Vahia, Zachary R. Smith, Zohra Chaudhry, Pallavi Bhargava, Joseph Miller, Rachel M. Kenney, George Alangaden, Mayur S. Ramesh, Henry Ford COVID-19 Management Task Force
medRxiv 2020.05.04.20074609; doi: https://doi.org/10.1101/2020.05.04.20074609

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (524)
  • Anesthesia (125)
  • Cardiovascular Medicine (1432)
  • Dentistry and Oral Medicine (219)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (589)
  • Epidemiology (10326)
  • Forensic Medicine (6)
  • Gastroenterology (533)
  • Genetic and Genomic Medicine (2652)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1744)
  • Health Policy (791)
  • Health Systems and Quality Improvement (680)
  • Hematology (269)
  • HIV/AIDS (570)
  • Infectious Diseases (except HIV/AIDS) (12116)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (274)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2478)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (496)
  • Occupational and Environmental Health (569)
  • Oncology (1332)
  • Ophthalmology (403)
  • Orthopedics (151)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (344)
  • Pediatrics (785)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2417)
  • Public and Global Health (5029)
  • Radiology and Imaging (900)
  • Rehabilitation Medicine and Physical Therapy (533)
  • Respiratory Medicine (687)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (300)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)